The present invention is directed to novel opioid receptor modulators of Formula. A trabecular stent is adapted for implantation within the trabecular meshwork of an eye such that intraocular liquid flows controllably from the anterior chamber of the eye to Schlemm’s canal, bypassing the trabecular meshwork. The fluid communication system is configured to provide chilled coolant to and exhaust heated coolant from coolant system components of each cooling rack. The tracking system then watches the state of the entity to detect when the entity enters the up state. A conveyor may be fit to run along the length of the applicator, within the gap. The number of the emission regions is 2 or more and 1000 or less, and the respective emission regions successively become luminous as the scanned light is incident on the respective light guide paths.